|HIV Specialist Dr. John G. Bartlett, MD Named to Leadership Team Of the Forum for Collaborative HIV Research|
Appointment Comes As the Organization Expands Its Role in Accelerating Scientific Advances in HIV/AIDS and Chronic Infection
The Forum for Collaborative HIV Research today announced that one of the nation’s top experts in HIV/AIDS research, treatment and public policy – John G. Bartlett, MD, Professor of Medicine in the Division of Infectious Diseases at The Johns Hopkins University School of Medicine – has joined the leadership team as the new co-chair of the Forum’s Executive Committee.
Building on more than a decade of identifying and addressing emerging issues in the prevention, care, and treatment of people affected by HIV/AIDS, Dr. Bartlett’s appointment brings valuable expertise and new thinking to the Forum at a time when the organization is expanding its mission to advance the research agenda in TB/HIV co-infection and the Hepatitis C virus (HCV). Immediate priorities for the Forum include setting global standards for new clinical trials in HIV and for monitoring long-term drug toxicity, addressing HCV drug resistance and setting the standard for clinical trial designs to establish efficacy for new anti-HCV compounds.
“The Forum is honored to have such a distinguished leader in HIV/AIDS working to help us chart the organization’s future course in improving the prevention, diagnosis, treatment and care of people living with HIV/AIDS and all chronic infections or co-infections,” said Dr. Veronica Miller, executive director of the Forum. “The addition ofDr. Bartlett to our leadership team creates a new level of excellence for the Forum and its programs.”
As the new co-chair of the Forum’s Executive Committee, Dr. Bartlett will drive the Forum’s strategies for accelerating scientific advances in HIV and chronic infection, working in collaboration with James Rooney of Gilead, the industry co-chair, and the 50-plus committee members who provide scientific and policy oversight to the Forum and fund its programs. Committee members represent all the stakeholders in the HIV/AIDS field – government, industry, academia, private foundations, public health, health insurance and the patient advocacy community.
“I firmly believe in the Forum’s mission of bridging the gap between the two worlds co-existing in HIV, hepatitis C and tuberculosis – the exciting world where medical science is producing major breakthroughs in treatment and the challenging world where social issues are impeding efforts to ensure all patients are treated, have access to care and are retained in care. This is what implementation science is all about,” said Dr. Bartlett. “It is simply a privilege to work with Forum, which is the foremost institution in applying implementation science to HIV/AIDS and chronic infection. I look forward to helping the Forum achieve its goal of setting the research strategy and significantly improving patient care.”